Malaria is one of the most devastating diseases afflicting humanity. It infects and debilitates about 600 million people and kills up to three million people every year, mainly in the wet tropical regions of the world. Children and pregnant women are at particularly high risk.
The malaria parasite is injected into humans by an infected mosquito. The parasites then infect healthy red blood cells, transforming them into sticky sacks containing up to thirty-two new daughter parasites. The hijacked red blood cells stick to blood vessel walls, thereby avoiding being flushed through the spleen and being destroyed there by the body's immune system.
WEHI scientists have revealed key elements in the parasite's "sticky sack" adhesion strategy. They have identified eight new proteins that transport the parasite's major adhesion factor, PfEMP1, to the surface of infected red cells, where it promotes the formation of sticky knobs. They have also shown that removal of just one of these proteins disrupts the ability of the parasite bag to stick to blood vessel walls.
This discovery has greatly enhanced our understanding of how the parasite commandeers the red blood cell for its own survival and avoids our immune defences. It also suggests that a drug that inactivates an essential adhesion protein would be an effective anti-malarial.
All currently available malaria drugs attempt to disrupt the metabolism or biological function of the parasite. Unfortunately, malaria parasites are evolving resistance to such drugs, suggesting that quite a different strategy may be required – hence the importance of targeting the "stickiness factors." The inability of the parasite to prevent its transport to the human spleen would lead to the parasite's natural destruction.
Source: Research Australia
Related stories:
Scientists discover what drives the development of a fatal form of malaria
Platelets – those tiny, unassuming cells that cause blood to clot and scabs to form when you cut yourself – play an important early role in promoting cerebral malaria, an often lethal complication that occurs mostly in children. Affecting as many as half a billion people in tropical and subtropical regions, malaria is one of the oldest recorded diseases and the parasite responsible for it, Plasmodium, among the most studied pathogens of all time. Still, cerebral malaria, which results from a combination of blood vessel and immune system dysfunction, is not well understood.
Research exposes new target for malaria drugs
The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development.
Gene variant found in those with African ancestry increases odds of HIV infection
A variant of a gene found only in people of African ancestry increases the odds of becoming infected with the human immunodeficiency virus (HIV-1) by 40 percent, according to a long-term study of African Americans reported in the [date] issue of the journal
Cell Host & Microbe, a publication of Cell Press. However, once people are infected, the same variant seems to protect against progression of the disease, allowing those who carry it to live about two years longer.
Discovery of key malaria proteins could mean sticky end for parasite
Scientists funded by the Wellcome Trust have identified a key mechanism that enables malaria-infected red blood cells to stick to the walls of blood vessels and avoid being destroyed by the body's immune system. The research, published today in the journal
Cell, highlights an important potential new target for anti-malarial drugs.
How the malaria parasite hijacks human red blood cells
A new study—done on a scale an order of magnitude greater than anything previously attempted in the field of malaria—has uncovered an arsenal of proteins produced by the malaria parasite that allows it to hijack and remodel human red blood cells, leaving the oxygen-carrying cells stiff and sticky. Those effects on the blood cells play a major role in the development of malaria, a disease responsible for millions of deaths every year, the researchers report in the July 11th issue of the journal
Cell, a Cell Press publication.
DNA test to revolutionise sheep worm control
CSIRO scientists have moved a step closer to developing a novel DNA test which has the potential to revolutionise management of one of the biggest threats to sheep health in Australia, the barber’s pole worm.
Researchers block transmission of malaria in animal tests
By disrupting the potassium channel of the malaria parasite, a team of researchers has been able to prevent new malaria parasites from forming in mosquitoes and has thereby broken the cycle of infection during recent animal tests.
Chemistry of Airborne Particulate -- Lung Interactions Revealed
Exactly how airborne particulates harm our lungs still puzzles epidemiologists, physicians, environmental scientists, and policy makers. Now California Institute of Technology researchers have found that they act by impairing the lungs' natural defenses against ozone.